Fintel reports that on May 29, 2026, Cantor Fitzgerald initiated coverage of Sensei Biotherapeutics (NasdaqCM:SNSE) with a Overweight recommendation. Analyst Price Forecast Suggests 189.94% Upside As ...

Today, Sensei announced the launch of Sensei Cloud Apps, a new cloud-based platform designed to help dental practices start each day prepared, stay connected to patients, and operate more efficiently ...

The winter had been a season of calamities, with one emergency or challenge after another. I needed respite and peace, or some kind of magical elixir to heal me. And while we like to think a simple ...

After already halving its workforce twice since 2022, Sensei Therapeutics is forging ahead with another deep round of cuts. The biotech on Friday said 65% of its staffers are set to leave the company.

Sensei Biotherapeutics is laying off 46% of its workforce as the cancer-focused biotech looks to preserve cash to take its immune checkpoint inhibitor through phase 2. The asset in question, dubbed ...

Fintel reports that on May 22, 2026, Citigroup initiated coverage of Sensei Biotherapeutics (NasdaqCM:SNSE) with a Buy recommendation. Analyst Price Forecast Suggests 190.43% Upside As of May 14, 2026 ...

Sensei Biotherapeutics Inc. (NASDAQ:SNSE) is one of the best performing NASDAQ stocks according to Wall Street analysts. On March 30, Sensei Biotherapeutics shifted its focus following the acquisition ...

A new app called Sensei has arrived today for Mac that lets you monitor and tweak performance to get the most out of your machine. Sensei features a beautiful user interface with rich icons and lots ...

In today’s challenging economic climate, small businesses are constantly battling financial obstacles. Lead Sensei, under the leadership of CEO Daniel Bradley, is stepping in as a ...

Presidio, a leading global technology services and solutions provider, today announced an expanded strategic partnership with TDK SensEI, a global leader in AI-powered industrial platforms. What began ...